These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 33053478)

  • 21.
    Nie T; Meng F; Zhou L; Lu F; Bie X; Lu Z; Lu Y
    J Agric Food Chem; 2021 Mar; 69(12):3751-3760. PubMed ID: 33565867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mining of Gram-Negative Surface-Active Enzybiotic Candidates by Sequence-Based Calculation of Physicochemical Properties.
    Vázquez R; Blanco-Gañán S; Ruiz S; García P
    Front Microbiol; 2021; 12():660403. PubMed ID: 34113327
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Monomodular Pseudomonas aeruginosa phage JG004 lysozyme (Pae87) contains a bacterial surface-active antimicrobial peptide-like region and a possible substrate-binding subdomain.
    Vázquez R; Seoane-Blanco M; Rivero-Buceta V; Ruiz S; van Raaij MJ; García P
    Acta Crystallogr D Struct Biol; 2022 Apr; 78(Pt 4):435-454. PubMed ID: 35362467
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Novel
    Cater K; Dandu VS; Bari SM; Lackey K; Everett GF; Hatoum-Aslan A
    mSphere; 2017; 2(2):. PubMed ID: 28357414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Broad Bactericidal Activity of the
    Antonova NP; Vasina DV; Lendel AM; Usachev EV; Makarov VV; Gintsburg AL; Tkachuk AP; Gushchin VA
    Viruses; 2019 Mar; 11(3):. PubMed ID: 30901901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lysin Therapy for Staphylococcus aureus and Other Bacterial Pathogens.
    Fischetti VA
    Curr Top Microbiol Immunol; 2017; 409():529-540. PubMed ID: 26728063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Bacteriophage lysins: progress and perspective--a review].
    Wang Y; Lu C
    Wei Sheng Wu Xue Bao; 2009 Oct; 49(10):1277-81. PubMed ID: 20069871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increasing the Antimicrobial Activity of Nisin-Based Lantibiotics against Gram-Negative Pathogens.
    Li Q; Montalban-Lopez M; Kuipers OP
    Appl Environ Microbiol; 2018 Jun; 84(12):. PubMed ID: 29625984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gram-Negative Bacterial Lysins.
    Ghose C; Euler CW
    Antibiotics (Basel); 2020 Feb; 9(2):. PubMed ID: 32054067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bacteriophage therapy: a revitalized therapy against bacterial infectious diseases.
    Matsuzaki S; Rashel M; Uchiyama J; Sakurai S; Ujihara T; Kuroda M; Ikeuchi M; Tani T; Fujieda M; Wakiguchi H; Imai S
    J Infect Chemother; 2005 Oct; 11(5):211-9. PubMed ID: 16258815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Engineered bacteriophage lysins as novel anti-infectives.
    Yang H; Yu J; Wei H
    Front Microbiol; 2014; 5():542. PubMed ID: 25360133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The N-terminal and central domain of colicin A enables phage lysin to lyse Escherichia coli extracellularly.
    Yan G; Liu J; Ma Q; Zhu R; Guo Z; Gao C; Wang S; Yu L; Gu J; Hu D; Han W; Du R; Yang J; Lei L
    Antonie Van Leeuwenhoek; 2017 Dec; 110(12):1627-1635. PubMed ID: 28730370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lysins: the arrival of pathogen-directed anti-infectives.
    Pastagia M; Schuch R; Fischetti VA; Huang DB
    J Med Microbiol; 2013 Oct; 62(Pt 10):1506-1516. PubMed ID: 23813275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exogenous lytic activity of SPN9CC endolysin against gram-negative bacteria.
    Lim JA; Shin H; Heu S; Ryu S
    J Microbiol Biotechnol; 2014 Jun; 24(6):803-11. PubMed ID: 24690638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural products that target the cell envelope.
    Page JE; Walker S
    Curr Opin Microbiol; 2021 Jun; 61():16-24. PubMed ID: 33662818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Phage-derived lysins as potential agents for eradicating biofilms and persisters.
    Sharma U; Vipra A; Channabasappa S
    Drug Discov Today; 2018 Apr; 23(4):848-856. PubMed ID: 29326076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The antibacterial activity of E. coli bacteriophage lysin lysep3 is enhanced by fusing the Bacillus amyloliquefaciens bacteriophage endolysin binding domain D8 to the C-terminal region.
    Wang S; Gu J; Lv M; Guo Z; Yan G; Yu L; Du C; Feng X; Han W; Sun C; Lei L
    J Microbiol; 2017 May; 55(5):403-408. PubMed ID: 28124780
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TSPphg Lysin from the Extremophilic Thermus Bacteriophage TSP4 as a Potential Antimicrobial Agent against Both Gram-Negative and Gram-Positive Pathogenic Bacteria.
    Wang F; Ji X; Li Q; Zhang G; Peng J; Hai J; Zhang Y; Ci B; Li H; Xiong Y; Deng X; Lin L
    Viruses; 2020 Feb; 12(2):. PubMed ID: 32050494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LysSAP26, a New Recombinant Phage Endolysin with a Broad Spectrum Antibacterial Activity.
    Kim S; Jin JS; Choi YJ; Kim J
    Viruses; 2020 Nov; 12(11):. PubMed ID: 33238548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of cationic dendrimers on antibacterial activity of phage endolysin against P. aeruginosa cells.
    Ciepluch K; Maciejewska B; Gałczyńska K; Kuc-Ciepluch D; Bryszewska M; Appelhans D; Drulis-Kawa Z; Arabski M
    Bioorg Chem; 2019 Oct; 91():103121. PubMed ID: 31310881
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.